COVID-19 outcomes in patients with hematologic disease
- 6 May 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 55 (11), 2180-2184
- https://doi.org/10.1038/s41409-020-0931-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and ApplicationAnnals of Internal Medicine, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling studyThe Lancet Infectious Diseases, 2020
- SARS-CoV-2 transmission in cancer patients of a tertiary hospital in WuhanPublished by Cold Spring Harbor Laboratory ,2020
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injuryThe Lancet, 2020
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Acute Respiratory Distress SyndromeJAMA, 2012
- Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patientsJournal of Clinical Virology, 2004